Evidence map›Paper›PMID 38036749›Full record

ArticleNature cell biology2023

Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche.

Yohan Gerber-Ferder, Jason Cosgrove, Aleria Duperray-Susini, Yoann Missolo-Koussou, Marine Dubois, Kateryna Stepaniuk, Manuela Pereira-Abrantes, Christine Sedlik, Sonia Lameiras, Sylvain Baulande and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Osteoimmunology in bone malignancies: a symphony with evil.Journal of the National Cancer Center · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Yohan Gerber-FerderInstitut Curie, Immunity and Cancer, PSL University, INSERM U932, Paris, France.
Jason CosgrovePSL University, Institut Curie Research Center, Sorbonne Université, CNRS UMR168, Laboratoire Physico Chimie Curie, Paris, France.
Aleria Duperray-SusiniInstitut Cochin, Leukemia and Niche Dynamics Laboratory, Université Paris Cité, INSERM, CNRS, Paris, France.
Yoann Missolo-KoussouInstitut Curie, Immunity and Cancer, PSL University, INSERM U932, Paris, France.
Marine DuboisInstitut Curie, Immunity and Cancer, PSL University, INSERM U932, Paris, France.
Kateryna StepaniukInstitut Cochin, Phagocytes and Cancer Immunology Laboratory, Université Paris Cité, INSERM U1016, CNRS UMR8104, Paris, France.
Manuela Pereira-AbrantesCancer Research Center of Lyon, Centre Léon Bérard, Université Claude Bernard Lyon 1, UMR INSERM 1052 CNRS 5286, Lyon, France.
Christine SedlikInstitut Curie, Immunity and Cancer, PSL University, INSERM U932, Paris, France.ORCID 0000-0001-8502-0905
Sonia LameirasInstitut Curie, ICGex Next-Generation Sequencing Platform, PSL University, Paris, France.
Sylvain BaulandeInstitut Curie, ICGex Next-Generation Sequencing Platform, PSL University, Paris, France.ORCID 0000-0003-3104-1684
Nathalie Bendriss-VermareCancer Research Center of Lyon, Centre Léon Bérard, Université Claude Bernard Lyon 1, UMR INSERM 1052 CNRS 5286, Lyon, France.
Pierre GuermonprezInstitut Pasteur, Dendritic Cells and Adaptive Immunity Unit, Université Paris Cité, Paris, France.
Diana PassaroInstitut Cochin, Leukemia and Niche Dynamics Laboratory, Université Paris Cité, INSERM, CNRS, Paris, France.
Leïla PeriéPSL University, Institut Curie Research Center, Sorbonne Université, CNRS UMR168, Laboratoire Physico Chimie Curie, Paris, France.ORCID 0000-0003-0798-4498
Eliane PiaggioInstitut Curie, Immunity and Cancer, PSL University, INSERM U932, Paris, France.
Julie HelftInstitut Cochin, Phagocytes and Cancer Immunology Laboratory, Université Paris Cité, INSERM U1016, CNRS UMR8104, Paris, France. julie.helft@inserm.fr.ORCID 0000-0002-2733-1972
Centre National de la Recherche Scientifique · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris Sciences et Lettres · FRDélégation Paris 5 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid cell infiltration of solid tumours generally associates with poor patient prognosis and disease severity

Indexed as

Bone MarrowBreast NeoplasmsBone Marrow CellsCell DifferentiationFemaleHematopoietic Stem CellsHumansMultipotent Stem CellsStem Cell Niche

Identifiers

PMID38036749
OpenAlexW4389175339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.